Differential persistence of neutralizing antibody against SARS-CoV-2 in post immunized Bangladeshi population
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Differential persistence of neutralizing antibody against SARS-CoV-2 in post immunized Bangladeshi population ; volume:12 ; number:1 ; day:29 ; month:8 ; year:2022 ; pages:1-11 ; date:12.2022
Scientific reports ; 12, Heft 1 (29.8.2022), 1-11, 12.2022
- Creator
-
Roy, Dipa
Rahman, Md. Mosfequr
Chaity, Arnaba Saha
Reza, Md. Abu
Haque, Ariful
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-022-18302-9
- URN
-
urn:nbn:de:101:1-2022111621060855941728
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 15.08.2025, 7:26 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Roy, Dipa
- Rahman, Md. Mosfequr
- Chaity, Arnaba Saha
- Reza, Md. Abu
- Haque, Ariful
- SpringerLink (Online service)
Other Objects (12)
Neutralizing antibody titres in SARS-CoV-2 infections
SARS-CoV-2 structural features may explain limited neutralizing-antibody responses
Persistence of neutralizing antibodies a year after SARS‐CoV‐2 infection in humans
A Multifunctional Neutralizing Antibody‐Conjugated Nanoparticle Inhibits and Inactivates SARS‐CoV‐2
A broadly neutralizing antibody protects Syrian hamsters against SARS-CoV-2 Omicron challenge
Neutralizing antibody responses 300 days after SARS‐CoV‐2 infection and induction of high antibody titers after vaccination
Microfluidic Diffusional Sizing (MDS) Measurements of Secretory Neutralizing Antibody Affinity Against SARS-CoV-2
The SARS-CoV-2 neutralizing antibody response to SD1 and its evasion by BA.2.86
Intranasal administration of a monoclonal neutralizing antibody protects mice against SARS-CoV-2 infection
Feasibility Studies of Nebulized SARS-CoV-2 Neutralizing Antibody in Mice and Cynomolgus Monkeys
Neutralizing and binding antibody responses to SARS-CoV-2 with hybrid immunity in pregnancy
Longitudinal effects of SARS-CoV-2 breakthrough infection on imprinting of neutralizing antibody responses
Neutralizing antibody titres in SARS-CoV-2 infections
SARS-CoV-2 structural features may explain limited neutralizing-antibody responses
Persistence of neutralizing antibodies a year after SARS‐CoV‐2 infection in humans
A Multifunctional Neutralizing Antibody‐Conjugated Nanoparticle Inhibits and Inactivates SARS‐CoV‐2
A broadly neutralizing antibody protects Syrian hamsters against SARS-CoV-2 Omicron challenge
Neutralizing antibody responses 300 days after SARS‐CoV‐2 infection and induction of high antibody titers after vaccination
Microfluidic Diffusional Sizing (MDS) Measurements of Secretory Neutralizing Antibody Affinity Against SARS-CoV-2
The SARS-CoV-2 neutralizing antibody response to SD1 and its evasion by BA.2.86
Intranasal administration of a monoclonal neutralizing antibody protects mice against SARS-CoV-2 infection
Feasibility Studies of Nebulized SARS-CoV-2 Neutralizing Antibody in Mice and Cynomolgus Monkeys
Neutralizing and binding antibody responses to SARS-CoV-2 with hybrid immunity in pregnancy
Longitudinal effects of SARS-CoV-2 breakthrough infection on imprinting of neutralizing antibody responses
Neutralizing antibody titres in SARS-CoV-2 infections
SARS-CoV-2 structural features may explain limited neutralizing-antibody responses
Persistence of neutralizing antibodies a year after SARS‐CoV‐2 infection in humans
A Multifunctional Neutralizing Antibody‐Conjugated Nanoparticle Inhibits and Inactivates SARS‐CoV‐2
A broadly neutralizing antibody protects Syrian hamsters against SARS-CoV-2 Omicron challenge
Neutralizing antibody responses 300 days after SARS‐CoV‐2 infection and induction of high antibody titers after vaccination
Microfluidic Diffusional Sizing (MDS) Measurements of Secretory Neutralizing Antibody Affinity Against SARS-CoV-2
The SARS-CoV-2 neutralizing antibody response to SD1 and its evasion by BA.2.86
Intranasal administration of a monoclonal neutralizing antibody protects mice against SARS-CoV-2 infection
Feasibility Studies of Nebulized SARS-CoV-2 Neutralizing Antibody in Mice and Cynomolgus Monkeys
Neutralizing and binding antibody responses to SARS-CoV-2 with hybrid immunity in pregnancy